2 min read.Updated: 20 Dec 2018, 09:52 AM ISTR. Sree Ram
The positive changes effected by the GSK-Pfizer merger do not automatically trickle down to Indian subsidiaries
Investors are excited about GlaxoSmithKline Plc’s (GSK) plan to split the firm into two entities—pharmaceuticals and consumer healthcare. The consumer healthcare arm has been given heft through its merger with Pfizer Inc.’s consumer business.
Recommended For You
Select your Category
Internet Not Available
Wait for it…
Log in to our website to save your bookmarks. It'll just take a moment.